New Savings.com report shows uptick in redemption rates
LOS ANGELES — Savings.com found a 10% increase in coupon redemptions for April 2014, leading the way for a robust May shopping season. The monthly report analyzes current retail sales trends and coupon redemption rates, and provides insight on the impact that those redemptions have on upcoming buying periods.
"Analyzing retail trends in the couponing industry provides deep insights into the ways consumers are purchasing across a wide range of retailers," said Seth Barnes, head of marketing at Savings.com. "Our ability to track coupon redemption rates allows us to predict consumers purchasing patterns and pinpoint how consumers are currently interacting with retailers."
The report also delved into redemption rate performance at Macy’s. In April, the retailer’s deal redemptions on Savings.com were up 60% compared to the same time last year. Other key insights share in the report include an emphasis on mobile: Savings.com grew 98% year-over year and more than half of the searches for household brands came from smartphones.
To view the full report, visit Savings.com/RetailReports.
Rite Aid names CIO
CAMP HILL, Pa. — Rite Aid has appointed Matt Lynch, an information technology executive with nearly 30 years of experience, as SVP and CIO.
Lynch succeeds Don Davis, who is retiring from the company after 14 years of service.
In this position, Lynch will be responsible for all aspects of the company’s technology and information operations, including computer systems, network infrastructure, telecommunications and data security, as well as the continued development and execution of Rite Aid’s immediate and long-term information technology strategy. Lynch will report to Frank Vitrano, Rite Aid’s senior EVP, CFO and chief administrative officer.
“Matt is a seasoned information technology professional with diverse business systems’ management and deep retail experience,” Vitrano said. “Additionally, his expertise with advanced systems — spanning all key business functions — will be extremely beneficial to Rite Aid as we continue to enhance our information technology and services platforms to help us achieve our dual goals of delivering a superior customer experience and driving continued growth for our company.”
Most recently, Lynch served as SVP and CIO for Dick’s Sporting Goods, a sporting goods retailer, overseeing the enterprise IT function for all brands and e-commerce businesses. Prior to joining Dick’s Sporting Goods, Lynch held various executive information technology positions at ShopKo.
Teva’s Synribo approved for home administration
JERUSALEM — Teva Pharmaceutical Industries on Monday announced that the Food and Drug Administration approved Synribo (omacetaxine mepesuccinate) for injection, to include home administration. With the announcement of the approval, physicians who treat adults with chronic or accelerated phase CML (who are no longer responding to or can’t tolerate two or more tyrosine kinase inhibitors) now have the option to allow patients to administer Synribo at home.
“As we continue to expand our oncology portfolio and services at Teva, the updated labeling for Synribo demonstrates our commitment to improving the overall experience and lowering barriers to treatment for people living with CML,” said Bill Campbell, VP and general manager, Teva Oncology. “Home administration can reduce the number of required doctor office visits for patients being treated with Synribo, while still maintaining close collaboration with their healthcare provider to manage their treatment regimen.”
Teva is finalizing a comprehensive specialty pharmacy support program, which will help facilitate home administration of Synribo for HCPs, their patients and caregivers. It’s expected to "go live" in the second quarter of 2014.
“As an oncology nurse practitioner who has treated CML patients for nearly 20 years, I’m thrilled to see this unique therapy become available for home administration,” said Sandra Corbin, CRNP at Calvert Hematology and Oncology. “Patients may initially express concern at the thought of self-injecting — but with training and support, most can become skilled at administering the subcutaneous injections.”